Fluorescence-guided system for breast cancer surgery margins
Part of Cancer clinical trials.
This trial tests a new imaging system that helps surgeons see if cancer cells remain after breast-conserving surgery. It may reduce the need for a second surgery by giving real-time feedback on the removed tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with invasive breast cancer, ductal carcinoma in situ (DCIS), or a mix of both.
- You are female and 18 years or older.
- You are scheduled to have breast-conserving surgery (lumpectomy).
- You have not had any prior surgery on the same breast for cancer, reconstruction, or implants.
- You have adequate organ function (based on blood tests) and a good activity level (ECOG 0 or 1).
- You are not pregnant, nursing, or planning to become pregnant during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of checking during surgery to make sure all the cancer is removed: a new microscopic imaging technique versus the standard frozen section method. If you are having breast-conserving surgery, this may help ensure clear margins and reduce the need for a second surgery.
This study compares two types of breast-conserving surgery for women who have already had chemotherapy before their operation. It aims to see if using a tiny camera (endoscope) leads to equally good long-term results as standard breast-conserving surgery.
This trial tests a new technology that helps doctors examine cells during surgery for early-stage breast cancer. It may help make the sentinel lymph node biopsy more accurate.
This trial tests a new imaging technique that uses a special dye and light to help surgeons see exactly where the tumor ends during breast cancer surgery, so they can remove the whole tumor while sparing healthy tissue. It may help reduce the chance of leaving cancer cells behind.
This trial tests a new laser scanner that helps doctors see if all cancer cells are removed during breast-conserving surgery, which might reduce the need for a second operation.
This trial tests a special dye and imaging technique to help surgeons see and remove sarcoma tumors more completely. The goal is to reduce the chance that cancer cells are accidentally left behind during surgery.
Hear when a new Breast-conserving Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.